Cardiac resynchronisation therapy with or without a defibrillator: individualising device prescription.

Autor: Straw S; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Mullens W; Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium., Witte KK; Department of Internal Medicine I, RWTH Aachen University, Aachen, Germany kwitte@ukaachen.de.
Jazyk: angličtina
Zdroj: Heart (British Cardiac Society) [Heart] 2022 Jul 13; Vol. 108 (15), pp. 1164-1166. Date of Electronic Publication: 2022 Jul 13.
DOI: 10.1136/heartjnl-2022-320909
Abstrakt: Competing Interests: Competing interests: SS has nothing to declare. WM has received research grants from Novartis, Vifor, Medtronic, Biotronik, Abbott and Boston Scientific. KKW has received speaker’s fees and honoraria from Medtronic and Abbott, and unconditional research grants from Medtronic.
Databáze: MEDLINE